Here, we showed that the TP53‐mutated samples were remarkably enriched in the senescence processes and then sought to develop a TP53 mutation‐related senescence prognostic risk‐score model for HCC on the basis of the The Cancer Genome Atlas (TCGA) cohort. The gene discussed is TP53; the disease is hepatocellular carcinoma.